2022. Identifying novel compounds against the mutational impact on the PSEN2 protein via molecular docking studies. Journal of Pharmaceutical Negative Results. (Oct. 2022), 1679–1685. DOI:https://doi.org/10.47750/pnr.2022.13.S04.201.